Viviana Moroso, Ph.D.

Director, Quality Control & Medical Writing Consultant

Portrait-of-Viviana-Moroso-Pharmetheus

Bio

  • Joined Pharmetheus in 2020, actively working in client projects, with continuous improvements, and providing medical writing support
  • Expertise includes medical writing and quality control across therapeutic areas
  • Previously worked as freelance Medical Writer and Editor where she prepared publications, conference presentations, medical communications, copyediting for publishers, and provided workshops on academic English writing, and as Laboratory Technician at Unilabs Pathology, Sweden
  • M.Sc. in Medical Biotechnology (2008) from the University of Trieste, Italy, and Ph.D. in Clinical and Basic Immunology (2011) from the Erasmus Medical Center, Rotterdam, the Netherlands
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Conditional versus unconditional covariate effects in pharmacometric models: implications for interpretation, communication, and reportingPopulation Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving NintedanibThe impact of misspecified covariate models on inclusion and omission bias when using fixed effects and full random effects modelsA tutorial on pharmacometric Markov modelsBimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativaFull random effects models (FREM): A practical usage guideProperties of the full random-effect modeling approach with missing covariate dataEfficient and relevant stepwise covariate model building for pharmacometrics [2]Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarityWriting reports of modelling and simulation analysis: Our experience in the field of pharmacometricsEfficient and relevant stepwise covariate model building for pharmacometrics [1]